Prof Stanislas Faguer from our team proposed to one of his patients with a very rare kidney disease a novel treatment aiming to compensate the very low levels of a protein called  high density lipoprotein (HDL) in this individual. Treatment with the compound CER-001 stopped further renal function decline and normalised blurred vision.

For details see:

Annals of Internal Medicine:

https://www.acpjournals.org/doi/10.7326/L20-1300?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

La Dépeche:

https://www.ladepeche.fr/2021/03/16/a-toulouse-une-molecule-oubliee-permet-de-traiter-une-maladie-rare-du-rein-9430980.php